Your browser doesn't support javascript.
loading
Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates.
Denard, Jerome; Jenny, Christine; Blouin, Véronique; Moullier, Philippe; Svinartchouk, Fedor.
Affiliation
  • Denard J; Biomarkers Department, Genethon, 1 bis rue de l'Internationale , Evry, France.
  • Jenny C; Biomarkers Department, Genethon, 1 bis rue de l'Internationale , Evry, France.
  • Blouin V; Université de Nantes-Inserm UMR649 , Nantes, France.
  • Moullier P; Université de Nantes-Inserm UMR649 , Nantes, France ; Molecular Genetics and Microbiology Department, University of Florida , Gainesville, Florida, USA.
  • Svinartchouk F; Biomarkers Department, Genethon, 1 bis rue de l'Internationale , Evry, France.
Mol Ther Methods Clin Dev ; 1: 14031, 2014.
Article in En | MEDLINE | ID: mdl-26015972
Vectors based on recombinant adeno-associated viruses (rAAV) attract a growing interest for human gene therapy. Recently, it was shown that many rAAV serotypes produced by transient transfection of human embryonic kidney 293 cell line (HEK293) are efficiently released into culture medium and functionally equivalent to those purified from cell lysates. Here, we report that HEK293 cells produce and secrete Galectin 3-binding protein (huG3BP), a protein that efficiently binds rAAV6 in vivo. Importantly, intracellular G3BP and secreted G3BP have different properties: while the secreted protein had the same electrophoretic mobility as serum huG3BP and interacted with rAAV6, intracellular protein migrated faster and did not bind rAAV6. Consequently, rAAV6 purified from culture medium (secreted, rAAV6-S) was physically associated with huG3BP while rAAV6 harvested from cell lysates (cellular, rAAV6-C) was huG3BP-free. After systemic injections, rAAV6-S bound to huG3BP was 3 times less efficient compared to rAAV6-C and induced an immune response against huG3BP protein. Our findings show that protein content of rAAVs purified from culture medium or from cell lysates can be different and these differences may impact vector efficacy and/or immune response.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Mol Ther Methods Clin Dev Year: 2014 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Mol Ther Methods Clin Dev Year: 2014 Document type: Article Affiliation country: France Country of publication: United States